Indian research and development and manufacturing arm of Slayback Pharma, based in Hyderabad, Telangana, and now part of Azurity Pharmaceuticals following the 2022 acquisition. Develops complex generic and specialty pharmaceutical products including injectables, ophthalmics and difficult to formulate dosage forms for the United States market, running formulation development, analytical development and regulatory filing work from its Indian site.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen